论文部分内容阅读
目的:观察马来酸桂哌齐特注射液治疗急性脑梗死的近期临床疗效。方法:将94例急性脑梗死患者随机分成两组,治疗组予马来酸桂哌齐特320 mg静脉滴注;对照组予舒血宁20 ml静脉滴注;分别于治疗前、后进行神经功能缺损程度评分,比较两组疗效。结果:治疗后治疗组NDS评分改善程度、总有效率明显优于对照组。结论:马来酸桂哌齐特注射液治疗急性脑梗死显著疗效,值得临床推广。
Objective: To observe the recent clinical efficacy of Cinepazide maleate injection in the treatment of acute cerebral infarction. Methods: Ninety-four patients with acute cerebral infarction were randomly divided into two groups. The treatment group was treated with cinepazide maleate 320 mg intravenously. The control group was given Shuxuening 20 ml intravenous drip. Before and after treatment, The degree of functional impairment score, compare the two groups curative effect. Results: After treatment, the treatment group NDS score improvement, the total effective rate was significantly better than the control group. Conclusion: Cinepazide maleate injection in the treatment of acute cerebral infarction significant effect, worthy of clinical promotion.